Polarean Imaging (LSE:POLX) Change In Receivables : £-0.06 Mil (TTM As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Polarean Imaging Change In Receivables?

Polarean Imaging's change in receivables for the quarter that ended in Jun. 2023 was £0.05 Mil. It means Polarean Imaging's Accounts Receivable declined by £0.05 Mil from Dec. 2022 to Jun. 2023 .

Polarean Imaging's change in receivables for the fiscal year that ended in Dec. 2022 was £-0.92 Mil. It means Polarean Imaging's Accounts Receivable increased by £0.92 Mil from Dec. 2021 to Dec. 2022 .

Polarean Imaging's Accounts Receivable for the quarter that ended in Jun. 2023 was £1.19 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Polarean Imaging's Days Sales Outstanding for the six months ended in Jun. 2023 was 1,942.32.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Polarean Imaging's liquidation value for the six months ended in Jun. 2023 was £6.92 Mil.

Polarean Imaging Change In Receivables Historical Data

The historical data trend for Polarean Imaging's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polarean Imaging Change In Receivables Chart

Polarean Imaging Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

Get a 7-Day Free Trial

-0.06

-0.01

0.21

-0.47

-0.92

Polarean Imaging Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Receivables	Get a 7-Day Free Trial								-0.04	-0.43	-0.80	-0.11	0.05

Polarean Imaging Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.06 Mil.

Polarean Imaging (LSE:POLX) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Polarean Imaging's Days Sales Outstanding for the quarter that ended in Jun. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1.192	/	0.112	*	91
=	1,942.32

2. In Ben Graham's calculation of liquidation value, Polarean Imaging's accounts receivable are only considered to be worth 75% of book value:

Polarean Imaging's liquidation value for the quarter that ended in Jun. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	7.825	-	2.62	+	0.75 * 1.192	+	0.5 * 1.633
=	6.92

Polarean Imaging Change In Receivables Related Terms

Thank you for viewing the detailed overview of Polarean Imaging's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Polarean Imaging (LSE:POLX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polarean Imaging PLC (LSE:POLX) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

PLLWF:USA 8ZF:Germany

Address

27-28 Eastcastle Street, London, GBR, W1W 8DH

Website

https://www.polarean.com

Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment being the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives most of the revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.

Polarean Imaging (LSE:POLX) Headlines

No Headlines